IL-20R Activation via rIL-19 Enhances Hematoma Resolution through the IL-20R1/ERK/Nrf2 Pathway in an Experimental GMH Rat Pup Model.
Shengpeng LiuJerry J FloresBo LiShuixiang DengGang ZuoJun PengJiping TangArne P NeyrinckPublished in: Oxidative medicine and cellular longevity (2021)
rIL-19 treatment improved hematoma clearance and attenuated neurological deficits induced by GMH, which was mediated through the upregulation of the IL-20R1/ERK/Nrf2 pathways. rIL-19 treatment may provide a promising therapeutic strategy for the GMH patient population.